In vivo function of Langerhans cells and dermal dendritic cells

Trends in Immunology

Volumn 31, Issue 12, 2010, Pages 446-451

  Kaplan, Daniel H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LANGERIN; OVALBUMIN;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELLULAR IMMUNITY; COMMENSALISM; CROSS PRESENTATION; DENDRITIC CELL; DERMIS; EPIDERMIS; IN VIVO STUDY; LANGERHANS CELL; METHODOLOGY; NONHUMAN; REVIEW; SENSITIZATION; SKIN ALLERGY;

ANIMALS; ANTIGEN PRESENTATION; BIOLOGICAL MARKERS; DERMATITIS, CONTACT; HUMANS; LANGERHANS CELLS; SKIN;

EID: 78649630548     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2010.08.006     Document Type: Review

References (53)

1. Merad M., et al. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat. Rev. Immunol. 2008, 8:935-947.
2. Borkowski T.A., et al. A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 1996, 184:2417-2422.
3. Ginhoux F., et al. Langerhans cells arise from monocytes in vivo. Nat. Immunol. 2006, 7:265-273.
4. Chorro L., et al. Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J. Exp. Med. 2009, 206:3089-3100.
5. Merad M., et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 2002, 3:1135-1141.
6. Romani N., et al. Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol. Rev. 2010, 234:120-141.
7. Kubo A., et al. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J. Exp. Med. 2009, 206:2937-2946.
8. Rescigno M. Identification of a new mechanism for bacterial uptake at mucosal surfaces, which is mediated by dendritic cells. Pathol. Biol. (Paris) 2003, 51:69-70.
9. Bursch L.S., et al. Identification of a novel population of Langerin+ dendritic cells. J. Exp. Med. 2007, 204:3147-3156.
10. Henri S., et al. CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J. Exp. Med. 2010, 207:189-206.
11. Kissenpfennig A., et al. Dynamics and function of Langerhans cells in vivo dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005, 22:643-654.
12. Eidsmo L., et al. Differential migration of epidermal and dermal dendritic cells during skin infection. J. Immunol. 2009, 182:3165-3172.
13. Henri S., et al. The dendritic cell populations of mouse lymph nodes. J. Immunol. 2001, 167:741-748.
14. Steinman R.M., Nussenzweig M.C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:351-358.
15. Jiang A., et al. Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 2007, 27:610-624.
16. Gebhardt T., et al. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat. Immunol. 2009, 10:524-530.
17. Kalesnikoff J., Galli S.J. New developments in mast cell biology. Nat. Immunol. 2008, 9:1215-1223.
18. Ginhoux F., et al. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J. Exp. Med. 2007, 204:3133-3146.
19. Poulin L.F., et al. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J. Exp. Med. 2007, 204:3119-3131.
20. Shklovskaya E., et al. Epidermal and dermal dendritic cells display differential activation and migratory behavior while sharing the ability to stimulate CD4+ T cell proliferation in vivo. J. Immunol. 2008, 181:418-430.
21. Ginhoux F., et al. The origin and development of nonlymphoid tissue CD103+ DCs. J. Exp. Med. 2009, 206:3115-3130.
22. Edelson B.T., et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J. Exp. Med. 2010, 207:823-836.
23. Furio L., et al. UVA radiation impairs phenotypic and functional maturation of human dermal dendritic cells. J. Invest. Dermatol. 2005, 125:1032-1038.
24. Aubin F. Mechanisms involved in ultraviolet light-induced immunosuppression. Eur. J. Dermatol. 2003, 13:515-523.
25. Merad M., et al. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat. Med. 2004, 10:510-517.
26. Kaplan D.H., et al. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 2005, 23:611-620.
27. Kaplan D.H., et al. Autocrine/paracrine TGF{beta}1 is required for the development of epidermal Langerhans cells. J. Exp. Med. 2007, 204:2545-2552.
28. Hildner K., et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 2008, 322:1097-1100.
29. Saito M., et al. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat. Biotechnol. 2001, 19:746-750.
30. Bennett C.L., et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 2005, 169:569-576.
31. Bobr A., et al. Acute ablation of Langerhans cells enhances skin immune responses. J. Immunol. 2010, 185:4724-4728.
32. Douillard P., et al. Mouse lymphoid tissue contains distinct subsets of langerin/CD207 dendritic cells, only one of which represents epidermal-derived Langerhans cells. J. Invest. Dermatol. 2005, 125:983-994.
33. Sung S.S., et al. A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J. Immunol. 2006, 176:2161-2172.
34. del Rio M.L., et al. Development and functional specialization of CD103+ dendritic cells. Immunol. Rev. 2010, 234:268-281.
35. Flacher V., et al. Expression of langerin/CD207 reveals dendritic cell heterogeneity between inbred mouse strains. Immunology 2008, 123:339-347.
36. Stoitzner P., et al. Langerhans cells cross-present antigen derived from skin. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:7783-7788.
37. Waithman J., et al. Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells. J. Immunol. 2007, 179:4535-4541.
38. Bursch L.S., et al. Langerhans cells are not required for the CD8 T cell response to epidermal self-antigens. J. Immunol. 2009, 182:4657-4664.
39. Nichols L.A., et al. Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes. J. Immunol. 2007, 179:993-1003.
40. Kim B.S., et al. Keratinocytes function as accessory cells for presentation of endogenous antigen expressed in the epidermis. J. Invest. Dermatol. 2009, 129:2805-2817.
41. Wang L., et al. Langerin expressing cells promote skin immune responses under defined conditions. J. Immunol. 2008, 180:4722-4727.
42. Bedoui S., et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat. Immunol. 2009, 10:488-495.
43. Gaspari, A.A. and Katz, S.I. (2001) Contact hypersensitivity. Curr. Protoc. Immunol. Chapter 4, Unit 4 2.
44. Honda, T. et al. (2010) Compensatory role of Langerhans cells and langerin-positive dermal dendritic cells in the sensitization phase of murine contact hypersensitivity. J. Allergy Clin. Immunol. 125, 1154-1156.
45. Igyarto B.Z., et al. Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10. J. Immunol. 2009, 183:5085-5093.
46. Wang B., et al. Cytokine knockouts in contact hypersensitivity research. Cytokine Growth Factor Rev. 2003, 14:381-389.
47. Nakae S., et al. IL-1-induced tumor necrosis factor-alpha elicits inflammatory cell infiltration in the skin by inducing IFN-gamma-inducible protein 10 in the elicitation phase of the contact hypersensitivity response. Int. Immunol. 2003, 15:251-260.
48. Shibaki A., Katz S.I. Activation through CD40 ligation induces functional Fas ligand expression by Langerhans cells. Eur. J. Immunol. 2001, 31:3006-3015.
49. Bennett C.L., et al. Langerhans cells are required for efficient presentation of topically applied hapten to T cells. J. Immunol. 2007, 179:6830-6835.
50. Nagao K., et al. Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:3312-3317.
51. Klechevsky E., et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 2008, 29:497-510.
52. Ding W., et al. Calcitonin gene-related peptide biases Langerhans cells toward Th2-type immunity. J. Immunol. 2008, 181:6020-6026.
53. Elentner A., et al. Langerhans cells are critical in the development of atopic dermatitis-like inflammation and symptoms in mice. J. Cell Mol. Med. 2009, 13:2658-2672.